News for Healthier Living
Children's Hospital Los Angeles Studies New Gene-Editing Approach for Sickle Cell Disease
Children's Hospital Los Angeles is participating in RESTORE, an early-stage clinical trial studying an investigational CRISPR-Cas9 therapy designed to directly modify the beta-globin gene in sickle cell disease.
July 27, 2026
August 1 2026July 31 2026July 30 2026July 29 2026July 28 2026July 27 2026July 26 2026July 25 2026July 24 2026July 23 2026July 22 2026July 21 2026July 20 2026
|
|
|
|
|